Ethnicity and Clinical Outcomes in Patients Hospitalized for COVID-19 in Spain: Results from the Multicenter SEMI-COVID-19 Registry

View/ Open
Author
Ramos-Rincón, José Manuel
Cobos-Palacios, Lidia
López-Sampalo, Almudena
Ricci, Michele
Rubio-Rivas, Manuel
Martos-Pérez, Francisco
Lalueza-Blanco, Antonio
Moragón-Ledesma, Sergio
Fonseca-Aizpuru, Eva-María
García-García, Gema-María
Beato-Pérez, José-Luis
Josa-Laorden, Claudia
Arnalich-Fernández, Francisco
Molinos-Castro, Sonia
Torres‑Peña, J.D.
Artero, Arturo
Vargas-Núñez, Juan-Antonio
Méndez-Bailón, Manuel
Loureiro-Amigo, Jose
Hernández-Garrido, María-Soledad
Peris-García, Jorge
López-Reboiro, Manuel-Lorenzo
Barón-Franco, Bosco
Casas-Rojo, José Manuel
Gómez-Huelgas, Ricardo
SEMI‐COVID‐19 Network
Publisher
MDPIDate
2022Subject
COVID-19SARS-CoV-2
Ethnic groups
Minority groups
Migrants
Spain
METS:
Mostrar el registro METSPREMIS:
Mostrar el registro PREMISMetadata
Show full item recordAbstract
This work aims to analyze clinical outcomes according to ethnic groups in patients hospitalized for COVID-19 in Spain. (2) Methods: This nationwide, retrospective, multicenter, observational study analyzed hospitalized patients with confirmed COVID-19 in 150 Spanish hospitals (SEMI-COVID-19 Registry) from 1 March 2020 to 31 December 2021. Clinical outcomes were assessed according to ethnicity (Latin Americans, Sub-Saharan Africans, Asians, North Africans, Europeans). The outcomes were in-hospital mortality (IHM), intensive care unit (ICU) admission, and the use of invasive mechanical ventilation (IMV). Associations between ethnic groups and clinical outcomes adjusted for patient characteristics and baseline Charlson Comorbidity Index values and wave were evaluated using logistic regression. (3) Results: Of 23,953 patients (median age 69.5 years, 42.9% women), 7.0% were Latin American, 1.2% were North African, 0.5% were Asian, 0.5% were Sub-Saharan African, and 89.7% were European. Ethnic minority patients were significantly younger than European patients (median (IQR) age 49.1 (40.5–58.9) to 57.1 (44.1–67.1) vs. 71.5 (59.5–81.4) years, p < 0.001). The unadjusted IHM was higher in European (21.6%) versus North African (11.4%), Asian (10.9%), Latin American (7.1%), and Sub-Saharan African (3.2%) patients. After further adjustment, the IHM was lower in Sub-Saharan African (OR 0.28 (0.10–0.79), p = 0.017) versus European patients, while ICU admission rates were higher in Latin American and North African versus European patients (OR (95%CI) 1.37 (1.17–1.60), p < 0.001) and (OR (95%CI) 1.74 (1.26–2.41), p < 0.001). Moreover, Latin American patients were 39% more likely than European patients to use IMV (OR (95%CI) 1.43 (1.21–1.71), p < 0.001). (4) Conclusion: The adjusted IHM was similar in all groups except for Sub-Saharan Africans, who had lower IHM. Latin American patients were admitted to the ICU and required IMV more often.
Fuente
Journal of Clinical Medicine 11(7), 1949 (2022)Versión del Editor
https://doi.org/10.3390/jcm11071949Related items
Showing items related by title, author, creator and subject.
-
In Vitro Activity of Tedizolid against Mycobacterium tuberculosis
Ruiz Martínez, P.; Causse, Manuel; Vaquero Abellán, Manuel; Casal Román, Manuel (American Society for Microbiology, 2019)Tedizolid is a novel oxazolidinone with activities against Gram-positive microorganisms, including mycobacteria. We studied the in vitro activity of tedizolid against 120 Mycobacterium tuberculosis strains, including ... -
Evaluation of a new automated Abbott RealTime MTB RIF/INH assay for qualitative detection of rifampicin/isoniazid resistance in pulmonary and extra-pulmonary clinical samples of Mycobacterium tuberculosis
Ruiz, Pilar; Causse, Manuel; Vaquero Abellán, Manuel; Casal Román, Manuel; Gutiérrez-Aroca, Juan-Bautista (Dovepress, 2017)A new automated real-time PCR assay for the detection of rifampicin (RIF) and isoniazid (INH) resistance in Mycobacterium tuberculosis (MTB) was evaluated. A total of 163 clinical samples (128 pulmonary and 35 extra-pulmonary) ... -
Surveillance of Drug-Resistant Tuberculosis in Spain (2001–2015)
Gutiérrez-Aroca, Juan-Bautista; Ruiz, Pilar; Vaquero Abellán, Manuel; Causse, Manuel; Casal Román, Manuel (Mary Ann Liebert, Inc., 2018)Multidrug-resistant (MDR) tuberculosis (TB) is a cause of increasing concern. This study investigated first-line anti-TB drug resistance in Mycobacterium tuberculosis strains submitted to the Tuberculosis Reference Center ...